专利号:WO-2012001578-A1 优先权日:2010-06-29 标 题 :Single-step synthesis of iron oxide nanoparticles 发明人:BURDINSKI DIRK; HAEX NICOLE PETRONELLA MARTIEN 权利人:KONINKL PHILIPS ELECTRONICS NV; BURDINSKI DIRK; HAEX NICOLE PETRONELLA MARTIEN 摘要:The invention provides methods for the synthesis of iron oxide nanoparticles and the particles obtainable by these methods. The particles can be used as tracer materials for magnetic particle imaging and for Magnetic Particle Spectroscopy (MPS). The method for the synthesis of these particles comprises the steps: (i) dissolving at least one water-soluble iron salt and at least one water-soluble stabilizer in water to form a reaction batch, (ii) adding at least one base to the reaction batch to yield a pH of 10 to 13, and (iii) exposing the reaction batch to a reaction temperature T R for a defined period of time DT, wherein T R ≥ 110°C, to obtain the iron oxide nanoparticles.
专利号:US-9401507-B2 优先权日:2012-08-07 标题:Methods for the colloidal synthesis of lithium iron phosphate 发明人:PAOLELLA ANDREA; CHANDRAMOHAN GEORGE; PRATO MIRKO; POVIA MAURO; GENOVESE ALESSANDRO; MANNA LIBERATO; CINGOLANI ROBERTO 权利人:FOND ST ITALIANO TECNOLOGIA 摘要:Methods for producing lithium iron phosphate or lithium manganese phosphate or lithium iron manganese phosphate, by colloidal synthesis are provided. Such methods include the operation of reacting a lithium salt, an iron(II) halide (and/or a manganese(II) halide) and a phosphorus compound, which, under the reaction conditions, is capable of releasing the phosphate ion, in the presence of an organic surfactant or a mixture of organic surfactants including an alkylamine or alkenylamine, in which the surfactant or mixture of surfactants is capable of dissolving the lithium salt and the iron halide (and/or the manganese halide), where used, in an organic solvent, which is liquid at room temperature, in which the surfactant or mixture of surfactants is soluble, the reaction being performed at a temperature not lower than 250° C.
专利号:US-2008300418-A1 优先权日:2004-11-08 标 题:Synthesis of Cardiolipin Analogues and Uses Thereof 发明人:AHMAD MOGHIS U; UKKALAM MURALI K; ALI SHOUKATH M; AHMAD IMRAN 权利人:AHMAD MOGHIS U; UKKALAM MURALI K; ALI SHOUKATH M; AHMAD IMRAN 摘要:The invention provides novel synthetic methodologies for preparing cardiolipin, migrated caridiolipin (1,2-positional isomer of cardiolipin) and their analogues having varying fatty acids and/or alkyl chains with varying length and degrees of saturation/unsaturation. The method comprises (a) reacting an optically pure 1,2-O-dialkyl-sn-glycerol or 1,2-O-dialkyl-sn-glycerol with one or more phosphoramidite reagent(s), wherein a phosphite triester is produced; (b) coupling the product of (a) with glycerol, wherein a protected cardiolipin is produced; and (c) deprotecting the protected cardiolipin, such that cardiolipin is prepared. The cardiolipins and analogues thereof, prepared by the present methods, can be incorporated into liposomes, which can also include active agents such as hydrophobic or hydrophilic drugs, antisense nucleotides or diagnostic agents. Such liposomes can be used to treat diseases or can be used in diagnostic and/or analytical assays.
专利号:US-2013345116-A1 优先权日:2012-06-21 标题 :Composition Containing Trail for Prevention or Treatment of Metabolic Diseases 发明人:LEE HYE-JEONG 权利人:LEE HYE-JEONG 摘要:The present invention provides a pharmaceutical composition and a food composition containing tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) as an active ingredient for prevention or treatment of metabolic diseases. The TRAIL according to the present invention can reduce blood glucose, neutral fat, cholesterol, and free fatty acid, and neutral fat in liver, and reduce the synthesis of fat, and promote the lipid metabolism, and thus can be effectively used for the prevention or treatment of metabolic diseases.
专利号:US-6538154-B2 优先权日:2000-12-11 标 题:Process for the preparation of cinnamic esters 发明人:KUHN WALTER; RICHTER NORBERT; WALTHER LUTZ 权利人:HAARMANN & REIMER GMBH 摘要:The present invention relates to a process for the synthesis of cinnamic esters and/or cinnamic acids by condensation of aldehydes with carboxylic anhydrides, using iron(II) salts as catalyst.
专利号:US-2006078560-A1 优先权日:2003-06-23 标 题 :Method of inducing apoptosis and inhibiting cardiolipin synthesis 发明人:JAMIL HARIS; AHMAD MOGHIS U; AHMAD IMRAN 权利人:NEOPHARM INC 摘要:The present invention provides a method for inducing apoptosis within a cell by exposing the cell to an inhibitor of cardiolipin synthesis under conditions sufficient to induce apoptosis within the cell. The method can be used to investigate or treat disorders such as cancer, obesity, and cardiovascular disorders. The invention also provides a pharmaceutical composition including an inhibitor of cardiolipin synthesis and a liposomal carrier.
摘要:Journal of Pharmaceutical Sciences., 54(1211), 1965 [] 摘要:USEPA/Office of Water; Federal-State Toxicology and Risk Analysis Committee (FSTRAC). Summary of State and Federal Drinking Water Standards and Guidelines (11/93) To Present 摘要:Lewis, R.J. Sax's Dangerous Properties of Industrial Materials. 9th ed. Volumes 1-3. New York, NY: Van Nostrand Reinhold, 1996., p. 2018 摘要: 摘要:American Conference of Governmental Industrial Hygienists. Documentation of the Threshold Limit Values and Biological Exposure Indices. 5th ed. Cincinnati, OH: American Conference of Governmental Industrial Hygienists, 1986., p. 328